Key Findings

In an unadjusted analysis, patients who are prescribed Paxlovid are about two times less likely to be hospitalized for COVID-19 and about four times less likely to die from COVID-19 than those who might be eligible for Paxlovid but did not receive a Paxlovid prescription.
Fully vaccinated patients over age 50 who were treated with Paxlovid are about three times less likely to be hospitalized than those not treated with Paxlovid.
Patients aged 40-49 are about two times less likely to be hospitalized when treated with Paxlovid, although results vary depending on vaccination status.